Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

DICE Therapeutics, Inc. (DICE)

15.7   -0.04 (-0.25%) 06-26 22:10
Open: 16.17 Pre. Close: 15.74
High: 17.25 Low: 15.57
Volume: 2,280,396 Market Cap: 600(M)
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lead therapeutic candidate is DC-806, an oral antagonist of the pro-inflammatory signaling molecule, interleukin-17, which is a validated drug target implicated in a various immunology indications. It is also developing oral therapeutic candidates targeting a4ß7 integrin for the treatment of inflammatory bowel diseases, as well as targeting aVß1/aVß6 integrin for the treatment of idiopathic pulmonary fibrosis. In addition, the company focuses on immuno-oncology for antibody therapeutics. The company was incorporated in 2013 and is headquartered in South San Francisco, California.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 17.26 - 17.35 17.35 - 17.42
Low: 15.38 - 15.47 15.47 - 15.53
Close: 15.56 - 15.71 15.71 - 15.82

Technical analysis

as of: 2022-06-24 4:39:16 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 21.16     One year: 24.71
Support: Support1: 14.73    Support2: 12.63
Resistance: Resistance1: 18.12    Resistance2: 21.16
Pivot: 14.47
Moving Average: MA(5): 15.09     MA(20): 14.46
MA(100): 17.42     MA(250): 0
MACD: MACD(12,26): -0.4     Signal(9): -0.8
Stochastic oscillator: %K(14,3): 81.2     %D(3): 75.4
RSI: RSI(14): 53.4
52-week: High: 40.49  Low: 12.63
Average Vol(K): 3-Month: 454 (K)  10-Days: 582 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ DICE ] has closed below upper band by 6.2%. Bollinger Bands are 36.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Sun, 26 Jun 2022
DICE Therapeutics (NASDAQ:DICE) Trading 6.9% Higher - Defense World

Sat, 25 Jun 2022
Dungeons and Dragons Player Shows Off Beautiful Liquid Core Dice - GameRant

Thu, 23 Jun 2022
Chet Holmgren explains meaning of his dice chain: 'I'm big on betting on myself' - Yardbarker

Thu, 23 Jun 2022
DICE Launches in Miami with Club Space Partnership - EDM Identity

Wed, 22 Jun 2022
A different menu: Pizza and board games at Slice and Dice Pizzeria - Rio Rancho Observer

Wed, 22 Jun 2022
DICE is 'only focusing' on Battlefield 2042, has no time for other projects right now - PC Gamer

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Underperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. 0 (M)
Shares Float 38 (M)
% Held by Insiders 2.419e+007 (%)
% Held by Institutions 4.1 (%)
Shares Short 2,310 (K)
Shares Short P.Month 0 (K)

Stock Financials

EPS -4.694e+007
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin (%) 0
Operating Margin (%) -4
Return on Assets (ttm) 231.3
Return on Equity (ttm) -15.3
Qtrly Rev. Growth 1.12e+006
Gross Profit (p.s.) -0.48
Sales Per Share 0.03
EBITDA (p.s.) -0.99
Qtrly Earnings Growth -11.2
Operating Cash Flow 0 (M)
Levered Free Cash Flow -39 (M)

Stock Valuations

PE Ratio -0.01
PEG Ratio 0.1
Price to Book value 0
Price to Sales 458.17
Price to Cash Flow 0

Stock Dividends

Dividend 0
Forward Dividend 2.59e+006
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.